Skip to main content

Tango Therapeutics, Inc.

TNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001819133

In the last 90 days, Tango Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 247 institutions reported holding it in 13F filings for Q2 2026, worth $6.60B in total; no superinvestor holds it.

13F holders, Q2 2023

Institutional positions in Tango Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
89
−3 vs. Q1 2023
Shares held
68.3M
−1.52M (−2.2%) vs. Q1 2023
Total value
$226.8M
−$49.0M (−17.8%) vs. Q1 2023
New holders
10
23 more added
Sold out
13
31 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TNGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 89 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 46 institutionsQ4 2021: 58 institutionsQ1 2022: 72 institutionsQ2 2022: 77 institutionsQ3 2022: 87 institutionsQ4 2022: 82 institutionsQ1 2023: 92 institutionsQ2 2023: 89 institutionsQ3 2023: 100 institutionsQ4 2023: 121 institutionsQ1 2024: 126 institutionsQ2 2024: 120 institutionsQ3 2024: 121 institutionsQ4 2024: 138 institutionsQ1 2025: 122 institutionsQ2 2025: 115 institutionsQ3 2025: 141 institutionsQ4 2025: 170 institutionsQ1 2026: 194 institutionsQ2 2026: 247 institutions
Value heldQ2 2023: $226.8M
Q1 2021: $0Q2 2021: $0Q3 2021: $844.9MQ4 2021: $741.0MQ1 2022: $528.2MQ2 2022: $319.1MQ3 2022: $246.8MQ4 2022: $498.4MQ1 2023: $275.9MQ2 2023: $226.8MQ3 2023: $999.9MQ4 2023: $927.1MQ1 2024: $781.2MQ2 2024: $846.0MQ3 2024: $781.2MQ4 2024: $329.2MQ1 2025: $147.0MQ2 2025: $651.7MQ3 2025: $1.18BQ4 2025: $1.53BQ1 2026: $3.78BQ2 2026: $6.60B
Institutions holding TNGX and their total value by quarter
QuarterHoldersValue
Q2 2026247$6.60B
Q1 2026194$3.78B
Q4 2025170$1.53B
Q3 2025141$1.18B
Q2 2025115$651.7M
Q1 2025122$147.0M
Q4 2024138$329.2M
Q3 2024121$781.2M
Q2 2024120$846.0M
Q1 2024126$781.2M
Q4 2023121$927.1M
Q3 2023100$999.9M
Q2 202389$226.8M
Q1 202392$275.9M
Q4 202282$498.4M
Q3 202287$246.8M
Q2 202277$319.1M
Q1 202272$528.2M
Q4 202158$741.0M
Q3 202146$844.9M
Q2 20210$0
Q1 20210$0

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Tango Therapeutics, Inc.; share changes are against Q1 2023.

Institutions holding TNGX in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Point72 Middle East FZE0$00.00%−3,583−100.0%Sold out
Federated Hermes, Inc.0$00.00%−412−100.0%Sold out